跳至主要内容
临床试验/NCT00645775
NCT00645775已完成不适用

The Efficacy of Irvingia Gabonensis (Bush Mango) in the Management of Overweight, Obesity and Metabolic Syndrome in Cameroon.

Gateway Health Alliance1 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2006年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
102
试验地点
1
主要终点
Weight change

研究概览

简要总结

The study investigated the use and efficacy of the seeds of African bush mango (Irvingia gabonensis)to control body weight, blood lipids and hormones in overweight and obese people.

详细描述

To assess the effects of seeds of Irvingia gabonensis on body weight, fasting blood glucose, plasma total and LDL cholesterol in 102 overweight and obese participants.

The study was a 10 week randomized, double blind, placebo controlled design. participants were randomly divided into 2 groups of 51 participants each. Group 1 was the placebo group, while Group 2 was the active group. Each group received 2 daily doses of 125 mg (before meals) of either placebo or Irvingia gabonensis.

Weight as well as fasting blood was taken at baseline and at 4, 8 and 10 weeks. No major detary changes or exercises were suggested during the study period.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 50 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • 未提供

排除标准

  • •Diabetics Pregnant and lactating Participating in any other weight reducing program Smokers

研究组 & 干预措施

1

Placebo Comparator

Compare active to placebo

干预措施: IGOB131 (Dietary Supplement)

结局指标

主要结局

Weight change

时间窗: 10 weeks

次要结局

  • Change in blood lipids and hormone levels(10 weeks)

研究者

发起方
Gateway Health Alliance
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

Effect of Irvingia Gabonensis (Bush Mango)on... | 临床试验